机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
Michael, LF
[1
]
Schkeryantz, JM
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
Schkeryantz, JM
[1
]
Burris, TP
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
Burris, TP
[1
]
机构:
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
Liver X receptors (LXRs) are members of the nuclear hormone receptor superfamily of ligand-activated transcription factors. Two LXRs (LXR alpha and LXR beta) were initially characterized as orphan members of this superfamily with disparate patterns of tissue expression. These two receptors later were recognized as sterol-responsive with the ability to directly bind several oxysterol metabolites. Many LXR target genes have been identified that implicate these receptors in a variety of physiological processes including cholesterol transport and metabolism, glucose metabolism, and inflammation. Synthetic LXR ligands have been designed with the potential to treat disorders such as atherosclerosis and diabetes. In this review, we describe the potential utility of LXR ligands in the treatment of disease.
机构:GlaxoSmithKline Res & Dev Ltd, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA
Goodwin, B
;
Watson, MA
论文数: 0引用数: 0
h-index: 0
机构:GlaxoSmithKline Res & Dev Ltd, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA
Watson, MA
;
Kim, H
论文数: 0引用数: 0
h-index: 0
机构:GlaxoSmithKline Res & Dev Ltd, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA
Kim, H
;
Miao, J
论文数: 0引用数: 0
h-index: 0
机构:GlaxoSmithKline Res & Dev Ltd, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA
Miao, J
;
Kemper, JK
论文数: 0引用数: 0
h-index: 0
机构:GlaxoSmithKline Res & Dev Ltd, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA
Kemper, JK
;
Kliewer, SA
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline Res & Dev Ltd, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USAGlaxoSmithKline Res & Dev Ltd, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA
机构:GlaxoSmithKline Res & Dev Ltd, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA
Goodwin, B
;
Watson, MA
论文数: 0引用数: 0
h-index: 0
机构:GlaxoSmithKline Res & Dev Ltd, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA
Watson, MA
;
Kim, H
论文数: 0引用数: 0
h-index: 0
机构:GlaxoSmithKline Res & Dev Ltd, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA
Kim, H
;
Miao, J
论文数: 0引用数: 0
h-index: 0
机构:GlaxoSmithKline Res & Dev Ltd, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA
Miao, J
;
Kemper, JK
论文数: 0引用数: 0
h-index: 0
机构:GlaxoSmithKline Res & Dev Ltd, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA
Kemper, JK
;
Kliewer, SA
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline Res & Dev Ltd, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USAGlaxoSmithKline Res & Dev Ltd, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA